☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
CTO
Medtronic Resolute Drug-Eluting Stent (DES) Platform Receives FDA's Approval for Expanded Indication for Chronic Total Occlusion (...
February 27, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.